<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle><![CDATA[SBIR Phase I:  Empowering Discovery of COVID-19 Vaccine through Large Scale Unsupervised Deeplearning for Electron Microscopy Data]]></AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>09/01/2020</AwardEffectiveDate>
<AwardExpirationDate>02/28/2022</AwardExpirationDate>
<AwardTotalIntnAmount>256000.00</AwardTotalIntnAmount>
<AwardAmount>256000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>15030000</Code>
<Directorate>
<Abbreviation>TIP</Abbreviation>
<LongName>Dir for Tech, Innovation, &amp; Partnerships</LongName>
</Directorate>
<Division>
<Abbreviation>TI</Abbreviation>
<LongName>Translational Impacts</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Peter Atherton</SignBlockName>
<PO_EMAI>patherto@nsf.gov</PO_EMAI>
<PO_PHON>7032928772</PO_PHON>
</ProgramOfficer>
<AbstractNarration><![CDATA[The broader impact of this Small Business Innovation Research (SBIR) Phase I project will be to empower researchers to make bio-structure discoveries by eliminating computational bottlenecks to shorten drug discovery cycles and time-to-market, such as those needed during the COVID-19 pandemic. Most modern drug discovery projects start with protein target identification and verification to obtain a 'verified drug target'. Structural vaccinology is a rational approach to generate an effective vaccine. For instance, knowing the structures of the proteins on the surface of the virus can guide vaccine design, and knowing the structures of viral enzymes can lead directly to drug treatments that inhibit replication. Cryo-electron microscopy (cryo-EM) is a method to image important structures. The proposed innovation enables fast classification of images and creation of 3-dimensional structures by using advanced deep learning techniques.  This will accelerate analysis and discovery by more than 50%. &lt;br/&gt;&lt;br/&gt;This Small Business Innovation Research (SBIR) Phase I project delivers an autonomous image processing pipeline for Cryo-EM data sets in real time at benchmark accuracies. On average, each cryo-EM microscope produces up to 2 TB of data daily. High-resolution image sizes from Cryo-EM are typically on the order of 10k x 10k pixels, requiring specialized software to process, classify and convert these images into 3D structures. Traditional fully supervised deep learning methods fail due to diversity of biomolecules and lack of labeled images. The proposed approach utilizes large-scale “deep unsupervised” learning methods that can train AI systems and deliver accurate results without labeled data on full resolution image sizes by use of High Performance Computing (HPC) clusters. The project involves development of cloud infrastructure software that eliminates GPU memory limitations. Further, the proposed machine learning approach dramatically accelerates and improves cryo-EM particle picking, both in 2-D images from single particle reconstruction workflows and in 3-D images of intact cells in electron tomography workflows at benchmark accuracies.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.]]></AbstractNarration>
<MinAmdLetterDate>08/19/2020</MinAmdLetterDate>
<MaxAmdLetterDate>10/14/2020</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2032548</AwardID>
<Investigator>
<FirstName>Vinay</FirstName>
<LastName>Rao</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Vinay Rao</PI_FULL_NAME>
<EmailAddress><![CDATA[vinay@rocketml.net]]></EmailAddress>
<NSF_ID>000761389</NSF_ID>
<StartDate>08/19/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>RocketML Inc</Name>
<CityName>LAKE OSWEGO</CityName>
<ZipCode>970356780</ZipCode>
<PhoneNumber>5039278954</PhoneNumber>
<StreetAddress>13026 SIERRA VISTA DR</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Oregon</StateName>
<StateCode>OR</StateCode>
<CONGRESSDISTRICT>05</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>OR05</CONGRESS_DISTRICT_ORG>
<ORG_UEI_NUM>JDJ2F5NZRC11</ORG_UEI_NUM>
<ORG_LGL_BUS_NAME>ROCKETML INC</ORG_LGL_BUS_NAME>
<ORG_PRNT_UEI_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[RocketML Inc]]></Name>
<CityName>Beaverton</CityName>
<StateCode>OR</StateCode>
<ZipCode>970050002</ZipCode>
<StreetAddress><![CDATA[3800 SW Cedar Hills Blvd]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Oregon</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>01</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>OR01</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>6856</Code>
<Text>ARTIFICIAL INTELL &amp; COGNIT SCI</Text>
</ProgramReference>
<ProgramReference>
<Code>7697</Code>
<Text>INSTRUMENTATION</Text>
</ProgramReference>
<ProgramReference>
<Code>8032</Code>
<Text>Software Services and Applications</Text>
</ProgramReference>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Fund>
<Code>01002021DB</Code>
<Name><![CDATA[NSF RESEARCH & RELATED ACTIVIT]]></Name>
<FUND_SYMB_ID>040100</FUND_SYMB_ID>
</Fund>
<FUND_OBLG>2020~256000</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p><strong id="docs-internal-guid-897d8ba0-7fff-b2fb-bf8e-164324cf3aef" style="font-weight: normal;"> </strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr">Introduction:</p> <p><strong id="docs-internal-guid-25d0d8b2-7fff-4721-a240-5b79a8fe01cc" style="font-weight: normal;"> </strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong id="docs-internal-guid-25d0d8b2-7fff-4721-a240-5b79a8fe01cc" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">RocketML, Inc. is purpose built to handle large scale machine learning on any data size or data type. It is a highly optimized framework comes with algorithms tuned to achieve upper limits of Amdahl's law regardless of problem type.&nbsp;</span></strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr">&nbsp;</p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong id="docs-internal-guid-25d0d8b2-7fff-4721-a240-5b79a8fe01cc" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">There are three layers to RocketML?s technology strategy. At the bottom most layer, RocketML is a systemsML platform built for Enterprises with large datasets. RocketML supports efficient data parallelism, model parallelism, and their combination. In the middle layer, an unsupervised deep learning module sits. This module utilizes techniques ranging from self-supervised, semi-supervised to fully unsupervised, enabling several autonomous, robust machine learning pipelines without significant data labeling and other manual activities. On the top layer, sits RocketML crown jewel, SciML generated models that reduce simulation run time by orders of magnitude.</span></strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"><br /></span></strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr">Project Scope:</p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong id="docs-internal-guid-897d8ba0-7fff-b2fb-bf8e-164324cf3aef" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"><strong id="docs-internal-guid-f1054bc3-7fff-244c-bbaf-2b216104810d" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">In both commercial and scientific business settings, enterprises/institutes collect vast amounts of structured and unstructured data. In the commercial segment (transportation, financials, ecommerce etc), computer vision machine learning approaches are well established based on imagenet data. This type of datasets are relatively easy to label (as in identifying cats, dogs and other common day to day objects). However in the science and engineering space, the domain knowledge required to label data for supervised learning becomes a major stumbling block to adopt modern machine learning techniques. This is where unsupervised learning methods become indispensable. These methods help find&nbsp; undiscovered patterns from superficially random data in huge datasets. This project addressed the specific need for reliable unsupervised methods for Electron microscopy use cases and minimized the need for costly human labeling. </span></strong></span></strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"><strong style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"><br /></span></strong></span></strong></p> <p>Notable Outcome:</p> <p><strong id="docs-internal-guid-611990e5-7fff-9f1b-14ea-37b0a30f1980" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cryo-EM datasets which are used in vaccine and drug discovery for Covid-19 are large and complex. RocketML?s Machine learning algorithms and framework delivers increase both the speed and accuracy of the data preparation steps for 3D structural analysis of biological interest.&nbsp; Our product dramatically accelerates and improves cryo-EM particle picking, both in 2-D images used for single particle reconstruction workflows as well as in 3-D images of intact cells in electron tomography workflows.</span></strong></p> <p>Broader Impact:</p> <p><strong id="docs-internal-guid-028f2cb0-7fff-1347-c18c-536ffb46abaa" style="font-weight: normal;"> </strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong id="docs-internal-guid-028f2cb0-7fff-1347-c18c-536ffb46abaa" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">As a society, we have never felt more urgency to speed up how drugs are developed than during the recent COVID-19 pandemic. Over the past few years, the world has experienced the greatest biological threat and healthcare crisis of our lifetime. Pandemics like COVID-19 can happen anytime. Our current drug discovery process is time consuming, expensive and largely unpredictable. While there are many causes, gaps in biological knowledge are the most significant driven by the heterogeneity and complexity of living beings. By enabling discoveries by machine learning methods, RocketML system overcomes some of the current shortcomings.&nbsp; By increasing speed and accuracy of biologically significant discoveries early on in the drug discovery pipeline, RocketML system improves the predictability of clinical outcome. It can aid in target identification and target validation steps of the Drug and Vaccine Discovery process.</span></strong></p> <p><strong id="docs-internal-guid-028f2cb0-7fff-1347-c18c-536ffb46abaa" style="font-weight: normal;"> <br /> </strong></p> <p style="line-height: 1.2; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;" dir="ltr"><strong id="docs-internal-guid-028f2cb0-7fff-1347-c18c-536ffb46abaa" style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Our software is also valuable in many applications and industries. Including semiconductor, energy, automotive in addition to pharmaceuticals.</span></strong></p> <p><strong id="docs-internal-guid-028f2cb0-7fff-1347-c18c-536ffb46abaa" style="font-weight: normal;"> </strong><br class="Apple-interchange-newline" /></p> <p>&nbsp;</p> <p>&nbsp;</p> <p><strong style="font-weight: normal;"><span style="font-size: 11pt; font-family: 'Proxima Nova',sans-serif; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"><br /></span></strong></p><br> <p>            Last Modified: 04/10/2022<br>      Modified by: Vinay&nbsp;Rao</p> </div> <div class="porSideCol"> <div class="each-gallery"> <div class="galContent" id="gallery0"> <div class="photoCount" id="photoCount0">          Images (<span id="selectedPhoto0">1</span> of <span class="totalNumber"></span>)           </div> <div class="galControls" id="controls0"></div> <div class="galSlideshow" id="slideshow0"></div> <div class="galEmbox" id="embox"> <div class="image-title"></div> </div> </div> <div class="galNavigation" id="navigation0"> <ul class="thumbs" id="thumbs0"> <li> <a href="/por/images/Reports/POR/2022/2032548/2032548_10699461_1649441265649_RMLstrategypyramid--rgov-214x142.jpg" original="/por/images/Reports/POR/2022/2032548/2032548_10699461_1649441265649_RMLstrategypyramid--rgov-800width.jpg" title="RocketML Strategic vision"><img src="/por/images/Reports/POR/2022/2032548/2032548_10699461_1649441265649_RMLstrategypyramid--rgov-66x44.jpg" alt="RocketML Strategic vision"></a> <div class="imageCaptionContainer"> <div class="imageCaption">RocketML platform</div> <div class="imageCredit">RocketML, Inc.</div> <div class="imagePermisssions">Copyrighted</div> <div class="imageSubmitted">Vinay&nbsp;Rao</div> <div class="imageTitle">RocketML Strategic vision</div> </div> </li> <li> <a href="/por/images/Reports/POR/2022/2032548/2032548_10699461_1649619472562_CryoWorkflow--rgov-214x142.jpg" original="/por/images/Reports/POR/2022/2032548/2032548_10699461_1649619472562_CryoWorkflow--rgov-800width.jpg" title="Fastest Way to build 3D protein model from raw Cryo-EM data"><img src="/por/images/Reports/POR/2022/2032548/2032548_10699461_1649619472562_CryoWorkflow--rgov-66x44.jpg" alt="Fastest Way to build 3D protein model from raw Cryo-EM data"></a> <div class="imageCaptionContainer"> <div class="imageCaption">Fastest Way to build 3D protein model from raw Cryo-EM data</div> <div class="imageCredit">RocketML, Inc.</div> <div class="imagePermisssions">Copyrighted</div> <div class="imageSubmitted">Vinay&nbsp;Rao</div> <div class="imageTitle">Fastest Way to build 3D protein model from raw Cryo-EM data</div> </div> </li> </ul> </div> </div> </div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[   Introduction:    RocketML, Inc. is purpose built to handle large scale machine learning on any data size or data type. It is a highly optimized framework comes with algorithms tuned to achieve upper limits of Amdahl's law regardless of problem type.    There are three layers to RocketML?s technology strategy. At the bottom most layer, RocketML is a systemsML platform built for Enterprises with large datasets. RocketML supports efficient data parallelism, model parallelism, and their combination. In the middle layer, an unsupervised deep learning module sits. This module utilizes techniques ranging from self-supervised, semi-supervised to fully unsupervised, enabling several autonomous, robust machine learning pipelines without significant data labeling and other manual activities. On the top layer, sits RocketML crown jewel, SciML generated models that reduce simulation run time by orders of magnitude.   Project Scope: In both commercial and scientific business settings, enterprises/institutes collect vast amounts of structured and unstructured data. In the commercial segment (transportation, financials, ecommerce etc), computer vision machine learning approaches are well established based on imagenet data. This type of datasets are relatively easy to label (as in identifying cats, dogs and other common day to day objects). However in the science and engineering space, the domain knowledge required to label data for supervised learning becomes a major stumbling block to adopt modern machine learning techniques. This is where unsupervised learning methods become indispensable. These methods help find  undiscovered patterns from superficially random data in huge datasets. This project addressed the specific need for reliable unsupervised methods for Electron microscopy use cases and minimized the need for costly human labeling.     Notable Outcome:  Cryo-EM datasets which are used in vaccine and drug discovery for Covid-19 are large and complex. RocketML?s Machine learning algorithms and framework delivers increase both the speed and accuracy of the data preparation steps for 3D structural analysis of biological interest.  Our product dramatically accelerates and improves cryo-EM particle picking, both in 2-D images used for single particle reconstruction workflows as well as in 3-D images of intact cells in electron tomography workflows.  Broader Impact:    As a society, we have never felt more urgency to speed up how drugs are developed than during the recent COVID-19 pandemic. Over the past few years, the world has experienced the greatest biological threat and healthcare crisis of our lifetime. Pandemics like COVID-19 can happen anytime. Our current drug discovery process is time consuming, expensive and largely unpredictable. While there are many causes, gaps in biological knowledge are the most significant driven by the heterogeneity and complexity of living beings. By enabling discoveries by machine learning methods, RocketML system overcomes some of the current shortcomings.  By increasing speed and accuracy of biologically significant discoveries early on in the drug discovery pipeline, RocketML system improves the predictability of clinical outcome. It can aid in target identification and target validation steps of the Drug and Vaccine Discovery process.      Our software is also valuable in many applications and industries. Including semiconductor, energy, automotive in addition to pharmaceuticals.                   Last Modified: 04/10/2022       Submitted by: Vinay Rao]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
